615 related articles for article (PubMed ID: 8104230)
1. Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
Brunda MJ; Luistro L; Warrier RR; Wright RB; Hubbard BR; Murphy M; Wolf SF; Gately MK
J Exp Med; 1993 Oct; 178(4):1223-30. PubMed ID: 8104230
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer.
Kundu N; Beaty TL; Jackson MJ; Fulton AM
J Natl Cancer Inst; 1996 Apr; 88(8):536-41. PubMed ID: 8606382
[TBL] [Abstract][Full Text] [Related]
3. Antitumor and antimetastatic activity of IL-23.
Lo CH; Lee SC; Wu PY; Pan WY; Su J; Cheng CW; Roffler SR; Chiang BL; Lee CN; Wu CW; Tao MH
J Immunol; 2003 Jul; 171(2):600-7. PubMed ID: 12847224
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.
Søndergaard H; Galsgaard ED; Bartholomaeussen M; Straten PT; Odum N; Skak K
J Immunother; 2010 Apr; 33(3):236-49. PubMed ID: 20445344
[TBL] [Abstract][Full Text] [Related]
5. In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells.
Brunda MJ; Bellantoni D; Sulich V
Int J Cancer; 1987 Sep; 40(3):365-71. PubMed ID: 3497883
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
Hafner M; Falk W; Echtenacher B; Männel DN
Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.
Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J
J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701
[TBL] [Abstract][Full Text] [Related]
9. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
[TBL] [Abstract][Full Text] [Related]
10. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.
Nastala CL; Edington HD; McKinney TG; Tahara H; Nalesnik MA; Brunda MJ; Gately MK; Wolf SF; Schreiber RD; Storkus WJ
J Immunol; 1994 Aug; 153(4):1697-706. PubMed ID: 7913943
[TBL] [Abstract][Full Text] [Related]
11. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
Markovic SN; Murasko DM
Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
[TBL] [Abstract][Full Text] [Related]
12. Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents.
Saijo N; Ozaki A; Beppu Y; Takahashi K; Fujita J; Sasaki Y; Nomori H; Kimata M; Shimizu E; Hoshi A
J Cancer Res Clin Oncol; 1984; 107(3):157-63. PubMed ID: 6736102
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12.
Rodríguez-Calvillo M; Duarte M; Tirapu I; Berraondo P; Mazzolini G; Qian C; Prieto J; Melero I
Exp Hematol; 2002 Mar; 30(3):195-204. PubMed ID: 11882356
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells.
Turner JG; Rakhmilevich AL; Burdelya L; Neal Z; Imboden M; Sondel PM; Yu H
J Immunol; 2001 Jan; 166(1):89-94. PubMed ID: 11123280
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumor efficacy in mice by combination treatment with interleukin-1 alpha and interferon-alpha.
Brunda MJ; Wright RB; Luistro L; Harbison ML; Anderson TD; McIntyre KW
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):233-41. PubMed ID: 8061895
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response.
Yajima T; Nishimura H; Wajjwalku W; Harada M; Kuwano H; Yoshikai Y
Int J Cancer; 2002 Jun; 99(4):573-8. PubMed ID: 11992548
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
